{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:59:00Z","timestamp":1784617140179,"version":"3.55.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.beha.2012.01.001","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T05:19:38Z","timestamp":1329887978000},"page":"101-117","source":"Crossref","is-referenced-by-count":42,"title":["HIV-associated lymphoma"],"prefix":"10.1016","volume":"25","author":[{"given":"Lawrence D.","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2012.01.001_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0889-8588(05)70380-4","article-title":"The epidemiology of AIDS-related neoplasms","volume":"10","author":"Biggar","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.beha.2012.01.001_bib2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/(SICI)1097-0215(19961211)68:6<754::AID-IJC11>3.0.CO;2-0","article-title":"Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Multistate AIDS\/Cancer Match Study Group","volume":"68","author":"Biggar","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2012.01.001_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980\u20132002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.beha.2012.01.001_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/QAD.0b013e3282f47082","article-title":"Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals","volume":"22","author":"Long","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.beha.2012.01.001_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/QAD.0b013e3282f2705d","article-title":"Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy","volume":"22","author":"Polesel","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.beha.2012.01.001_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<645::AID-IJC6>3.0.CO;2-X","article-title":"Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS\/Cancer Study Group","volume":"73","author":"Cot\u00e9","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.beha.2012.01.001_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cncr.21562","article-title":"Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy","volume":"106","author":"Diamond","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2012.01.001_bib8","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1200\/JCO.2008.18.2683","article-title":"Autologous stem-cell transplantation in patients with HIV-related lymphoma","volume":"27","author":"Balsalobre","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ajh.21259","article-title":"Plasmablastic lymphoma: one or more entities?","volume":"83","author":"Carbone","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2012.01.001_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00126334-200204010-00014","article-title":"Pleural and peritoneal lymphoma among people with AIDS in the United States","volume":"29","author":"Mbulaiteye","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.beha.2012.01.001_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00001622-199609000-00007","article-title":"AIDS primary central nervous system lymphoma","volume":"8","author":"Flinn","year":"1996","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/01.qai.0000371677.48743.8d","article-title":"Immunologic and virologic predictors of AIDS-related non-Hodgkin lymphoma in the highly active antiretroviral therapy era","volume":"54","author":"Engels","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.beha.2012.01.001_bib13","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1470-2045(09)70282-7","article-title":"Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study","volume":"10","author":"Guiguet","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/599313","article-title":"Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma","volume":"200","author":"Zoufaly","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.beha.2012.01.001_bib15","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1182\/blood-2010-03-275917","article-title":"AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and\/or biology?","volume":"116","author":"Guech-Ongey","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0002-9343(01)01020-8","article-title":"Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes","volume":"111","author":"Gabarre","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2012.01.001_bib17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0889-8588(05)70388-9","article-title":"Biology and management of AIDS-associated primary CNS lymphomas","volume":"10","author":"Forsyth","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.beha.2012.01.001_bib18","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.bjc.6605756","article-title":"Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study","volume":"103","author":"Franceschi","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2012.01.001_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1570162043351237","article-title":"Pathogenesis of HIV-associated non-Hodgkin lymphoma","volume":"2","author":"Killebrew","year":"2004","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.beha.2012.01.001_bib20","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2006-11-055764","article-title":"Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1","volume":"109","author":"Biancotto","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1470-2045(03)00957-4","article-title":"Emerging pathways in the development of AIDS-related lymphomas","volume":"4","author":"Carbone","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib22","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1172\/JCI119315","article-title":"Epstein\u2013Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma","volume":"99","author":"Kersten","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beha.2012.01.001_bib23","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/blood-2005-01-0432","article-title":"Loss of EBNA1-specific memory CD4+ and CD8+T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma","volume":"106","author":"Piriou","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib24","first-page":"79","article-title":"Epstein-Barr virus and AIDS-related primary central nervous system lymphoma. Viral detection by immunohistochemistry, RNA in situ hybridization, and polymerase chain reaction","volume":"15","author":"Guterman","year":"1996","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.beha.2012.01.001_bib25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2141.2005.05613.x","article-title":"AIDS-related lymphomas: from pathogenesis to pathology","volume":"130","author":"Carbone","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2012.01.001_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib27","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.pas.0000173023.02724.1f","article-title":"Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein\u2013Barr virus-associated extramedullary plasmacytic neoplasm","volume":"29","author":"Dong","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2012.01.001_bib28","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/0046-8177(95)90192-2","article-title":"Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein\u2013Barr virus","volume":"26","author":"Siebert","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.beha.2012.01.001_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3324\/haematol.2008.002691","article-title":"CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK","volume":"94","author":"Bower","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2012.01.001_bib30","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejim.2009.01.004","article-title":"Evolution of the incidence and aetiology of fever of unknown origin (FUO), and survival in HIV-infected patients after HAART (Highly Active Antiretroviral Therapy)","volume":"20","author":"Abell\u00e1n-Mart\u00ednez","year":"2009","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.beha.2012.01.001_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000201447","article-title":"Malignant gastrointestinal lymphomas in patients with AIDS","volume":"58","author":"Heise","year":"1997","journal-title":"Digestion"},{"key":"10.1016\/j.beha.2012.01.001_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cncr.21562","article-title":"Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival","volume":"106","author":"Diamond","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2012.01.001_bib33","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2012.01.001_bib34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/00002030-200304110-00011","article-title":"Leptomeningeal disease in AIDS-related non-Hodgkin's lymphoma","volume":"17","author":"Sarker","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.beha.2012.01.001_bib35","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.2000.18.19.3325","article-title":"Epstein\u2013Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas","volume":"18","author":"Cingolani","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib36","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2004-05-1982","article-title":"High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology","volume":"105","author":"Hegde","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3324\/haematol.11767","article-title":"Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART","volume":"93","author":"Navarro","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2012.01.001_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0025-7125(05)70528-9","article-title":"Human immunodeficiency virus-associated lymphomas","volume":"81","author":"Straus","year":"1997","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.beha.2012.01.001_bib39","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ajh.21250","article-title":"HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases","volume":"83","author":"Castillo","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2012.01.001_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1473-3099(08)70067-7","article-title":"Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection","volume":"8","author":"Riedel","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.beha.2012.01.001_bib41","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1200\/JCO.2003.06.013","article-title":"Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study","volume":"21","author":"Simonelli","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib42","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1182\/blood.V77.5.1057.1057","article-title":"Myc rearrangements and translocations involving band 8q24 in diffuse large-cell lymphomas","volume":"77","author":"Ladanyi","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib43","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.beha.2012.01.001_bib44","first-page":"43","article-title":"The staging of non-Hodgkin's lymphomas","volume":"17","author":"Moormeier","year":"1990","journal-title":"Semin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib45","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology","volume":"101","author":"Little","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib46","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood-2009-08-231613","article-title":"Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma","volume":"115","author":"Sparano","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib47","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2004-08-3300","article-title":"Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials","volume":"105","author":"Spina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib48","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1200\/JCO.2005.05.4684","article-title":"Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma","volume":"24","author":"Bou\u00e9","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib49","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.1998.16.11.3601","volume":"16","author":"Straus","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib50","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood-2005-09-3600","article-title":"AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy","volume":"107","author":"Mounier","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-143-4-200508160-00007","article-title":"A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy","volume":"143","author":"Bower","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beha.2012.01.001_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1634\/theoncologist.2009-0304","article-title":"Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma","volume":"15","author":"Castillo","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.beha.2012.01.001_bib53","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","author":"Hans","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib54","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1200\/JCO.2005.02.9355","article-title":"Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy","volume":"23","author":"Lim","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib55","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/cncr.21759","volume":"106","author":"Weiss","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2012.01.001_bib56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B","article-title":"Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma","volume":"91","author":"Vaccher","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2012.01.001_bib57","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00002030-200108170-00005","article-title":"Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy","volume":"15","author":"Antinori","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.beha.2012.01.001_bib58","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood-2004-05-1747","article-title":"Protease inhibitors potentiate chemotherapy-induced neutropenia","volume":"104","author":"Bower","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2012.01.001_bib59","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","article-title":"Chemotherapy for human immunodeficiency virus-associated non-Hodgkin\u2019s lymphoma in combination with highly active antiretroviral therapy","volume":"19","author":"Ratner","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2012.01.001_bib61","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2141.2007.06943.x","article-title":"Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial","volume":"140","author":"Ribera","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2012.01.001_bib62","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","article-title":"Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010","volume":"106","author":"Kaplan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib63","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V99.8.2685","article-title":"Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy","volume":"99","author":"Wilson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib64","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1182\/blood-2009-11-253039","article-title":"The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma","volume":"115","author":"Dunleavy","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib65","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","article-title":"Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma","volume":"113","author":"Dunleavy","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib66","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1200\/JCO.2005.11.973","article-title":"AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy","volume":"23","author":"Lim","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib67","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/1042819031000141301","article-title":"Magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity Leuk","volume":"45","author":"Lacasce","year":"2004","journal-title":"Lymphoma"},{"key":"10.1016\/j.beha.2012.01.001_bib68","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.11628","article-title":"Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma","volume":"98","author":"Wang","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2012.01.001_bib69","article-title":"Feasibility and toxicity of a modified dose intensive R-CODOX-M\/IVAC for HIV-associated Burkitt and atypical Burkitt lymphoma (BL): preliminary results of a prospective multicenter phase II trial of the AIDS Malignancy Consortium (AMC)","volume":"114","author":"Noy","year":"2009","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"10.1016\/j.beha.2012.01.001_bib70","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdh399","article-title":"CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients","volume":"15","author":"Teruya-Feldstein","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib71","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00042560-200112150-00002","article-title":"High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma","volume":"28","author":"Bi","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.beha.2012.01.001_bib72","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(00)02041-9","article-title":"High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma","volume":"355","author":"Gabarre","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2012.01.001_bib73","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2004-04-1532","article-title":"Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas","volume":"105","author":"Krishnan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib74","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2009-02-202762","article-title":"High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors","volume":"114","author":"Re","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib75","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11904-010-0050-8","article-title":"Hematopoietic stem cell transplantation in patients infected with HIV","volume":"7","author":"Serrano","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.beha.2012.01.001_bib76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbmt.2007.03.014","article-title":"Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020","volume":"14","author":"Spitzer","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2012.01.001_bib77","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bbmt.2009.03.023","article-title":"Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research","volume":"15","author":"Gupta","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.beha.2012.01.001_bib78","first-page":"346","article-title":"Primary CNS lymphoma","volume":"26","author":"Maher","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib79","first-page":"563","article-title":"The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features","volume":"18","author":"Johnson","year":"1997","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.beha.2012.01.001_bib80","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s003300050260","article-title":"CNS involvement in AIDS: spectrum of CT and MR findings","volume":"7","author":"Thurnher","year":"1997","journal-title":"Eur Radiol"},{"key":"10.1016\/j.beha.2012.01.001_bib81","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.48.3.687","article-title":"Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF","volume":"48","author":"Antinori","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.beha.2012.01.001_bib82","first-page":"199","article-title":"Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL)","volume":"9","author":"Raez","year":"1998","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.beha.2012.01.001_bib83","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3171\/jns.1990.73.2.0206","article-title":"Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome","volume":"73","author":"Baumgartner","year":"1990","journal-title":"J Neurosurg"},{"key":"10.1016\/j.beha.2012.01.001_bib84","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/00002030-199714000-00009","article-title":"Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS","volume":"11","author":"Jacomet","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.beha.2012.01.001_bib85","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1200\/JCO.2003.03.036","article-title":"Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07","volume":"21","author":"Batchelor","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib86","series-title":"Newly diagnosed patients with primary CNS lymphoma: results of CALGB 50202","first-page":"763","article-title":"Intensive chemotherapy and immunotherapy, without brain irradiation","volume":"vol. 116","author":"Rubenstein","year":"2010"},{"key":"10.1016\/j.beha.2012.01.001_bib87","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2008.19.6626","article-title":"Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection","volume":"27","author":"Powles","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib88","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib89","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cncr.11459","article-title":"Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988\u20131998","volume":"98","author":"Glaser","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2012.01.001_bib90","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1586\/14737140.4.3.401","article-title":"Current treatment strategies for patients with Hodgkin's lymphoma and HIV infection","volume":"4","author":"Hartmann","year":"2004","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.beha.2012.01.001_bib91","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00042560-200008150-00009","volume":"24","author":"Levine","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.beha.2012.01.001_bib92","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO.1995.13.7.1758","article-title":"Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors","volume":"13","author":"Tirelli","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib93","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3324\/haematol.10479","article-title":"Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma","volume":"92","author":"Xicoy","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2012.01.001_bib94","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood-2002-03-0989","article-title":"Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection","volume":"100","author":"Spina","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2012.01.001_bib95","first-page":"iv152","article-title":"VEBEP regimen and highly active antiretroviral therapy (HAART) in patients (pts) with HD and HIV infection (HD-HIV)","volume":"19","author":"Spina","year":"2008","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.beha.2012.01.001_bib96","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/annonc\/mdg408","article-title":"BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection","volume":"14","author":"Hartmann","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib97","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.3816\/CLML.2010.n.025","article-title":"Excessive neurotoxicity with ABVD when combined with protease inhibitor-based antiretroviral therapy in the treatment of AIDS-related Hodgkin lymphoma","volume":"10","author":"Cheung","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.beha.2012.01.001_bib98","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1200\/JCO.2005.02.7243","article-title":"Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma","volume":"23","author":"Martin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2012.01.001_bib99","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2007.06598.x","article-title":"G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis","volume":"137","author":"Evens","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2012.01.001_bib100","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1073\/pnas.1630810100","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile","volume":"100","author":"Jenner","year":"2003","journal-title":"Proc Natl Acad Sci USA"}],"updated-by":[{"DOI":"10.1016\/j.beha.2024.101554","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692612000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692612000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T21:02:12Z","timestamp":1593723732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692612000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1521692612000023"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2012.01.001","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}